Albert Waichow Young
CIK 1725420 · View on SEC EDGAR ↗
Insider
First SEC filing: March 29, 2018 · Latest: March 29, 2018
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 20 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2022 | ASTH | J | 984,042 | — | — | 10,191,660 Indirect | -8.81% | Disposed | (price as of 2026-08-21) |
| Dec. 2, 2022 | ASTH | J | 19,506 | — | — | 1,184,749 Direct | +1.67% | Acquired | (price as of 2026-08-21) |
| Nov. 29, 2022 | ASTH | M | 28,406 | $10.00 | $284,060 | 1,138,415 Direct | +2.56% | Acquired | 291.5% (price as of 2026-08-21) |
| Nov. 29, 2022 | ASTH | M | 26,828 | $11.00 | $295,108 | 1,165,243 Direct | +2.36% | Acquired | 255.9% (price as of 2026-08-21) |
| Nov. 29, 2022 | ASTH | M | 28,406 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Nov. 29, 2022 | ASTH | M | 26,828 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| March 31, 2022 | ASTH | F | 256 | $48.47 | $12,408 | 1,110,009 Direct | -0.02% | Disposed | -19.2% (price as of 2026-08-21) |
| March 31, 2021 | ASTH | F | 256 | $27.09 | $6,935 | 1,018,387 Direct | -0.03% | Disposed | 44.5% (price as of 2026-08-21) |
| Dec. 22, 2020 | ASTH | J | 96,877 | — | — | 1,115,265 Direct | +9.51% | Acquired | (price as of 2026-08-21) |
| June 15, 2020 | ASTH | M | 35,069 | $9.00 | $315,621 | 1,001,109 Direct | +3.63% | Acquired | 335.0% (price as of 2026-08-21) |
| June 15, 2020 | ASTH | M | 17,534 | $10.00 | $175,340 | 1,018,643 Direct | +1.75% | Acquired | 291.5% (price as of 2026-08-21) |
| June 15, 2020 | ASTH | M | 35,069 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| June 15, 2020 | ASTH | M | 17,534 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| March 31, 2020 | ASTH | F | 256 | $12.92 | $3,308 | 966,040 Direct | -0.03% | Disposed | 203.0% (price as of 2026-08-21) |
| Feb. 5, 2020 | ASTH | A | 1,880 | — | — | 966,296 Direct | +0.19% | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2020 | ASTH | J | 1,885 | — | — | 916,446 Direct | -0.21% | Disposed | (price as of 2026-08-21) |
| Feb. 5, 2020 | ASTH | A | 1,880 | — | — | 918,326 Direct | +0.21% | Acquired | (price as of 2026-08-21) |
| Dec. 8, 2019 | ASTH | A | 93,450 | — | — | 17,158,389 Indirect | +0.55% | Acquired | (price as of 2026-08-21) |
| Dec. 8, 2019 | ASTH | A | 47,970 | — | — | 966,301 Direct | +5.22% | Acquired | (price as of 2026-08-21) |
| Nov. 27, 2019 | ASTH | A | 1,885 | — | — | 918,331 Direct | +0.21% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 29, 2022 | ASTH | Warrants to purchase Common Stock | Common Stock (28,406) | $10.00 | Dec. 8, 2022 | 28,406 | Disposed |
| Nov. 29, 2022 | ASTH | Warrants to purchase Common Stock | Common Stock (26,828) | $11.00 | Dec. 8, 2022 | 26,828 | Disposed |
| June 15, 2020 | ASTH | Warrants to Purchase Common Stock | Common Stock (35,069) | $9.00 | Oct. 14, 2020 | 35,069 | Disposed |
| June 15, 2020 | ASTH | Warrants to Purchase Common Stock | Common Stock (17,534) | $10.00 | March 30, 2021 | 17,534 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 29, 2018 | ASTH | Common Stock [F1,F2] | 863,475 | Direct |
| March 29, 2018 | ASTH | Common Stock [F3,F4] | 1,682,109 | Indirect |
| Dec. 18, 2017 | ASTH | Common Stock [F1,F2] | 854,207 | Direct |
| Dec. 18, 2017 | ASTH | Common Stock [F3,F6] | 1,664,054 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F4]→ Common Stock (35,069) | 35,069 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F4]→ Common Stock (17,535) | 17,535 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F2]→ Common Stock (28,406) | 28,406 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F2]→ Common Stock (26,828) | 26,828 | Direct |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F5]→ Common Stock (68,317) | 68,317 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F5]→ Common Stock (34,159) | 34,159 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F6]→ Common Stock (55,337) | 55,337 | Indirect |
| Dec. 18, 2017 | ASTH | Warrants to purchase Common Stock [F3,F6]→ Common Stock (52,263) | 52,263 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ASTH
M.D., M.P.H. SVP of Health Affairs (former Chief Administrative Officer)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $400,000 | $39,000 | — | — | — | — | $13,281 | $452,281 |
| 2022 | $400,000 | $150,000 | — | — | — | — | $23,673 | $573,673 |
| 2021 | $400,000 | — | — | — | — | — | $53,726 | $453,726 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.